Welcome!

Microsoft Cloud Authors: Andreas Grabner, Stackify Blog, Liz McMillan, David H Deans, Automic Blog

News Feed Item

Liberator Medical Reports Record Annual Net Revenues of $60.9 Million for Fiscal Year Ended September 30, 2012

The Company Reports Net Income of $2.5 Million for the Year

STUART, FL--(Marketwire - December 24, 2012) -  Liberator Medical Holdings, Inc. (OTCBB: LBMH) announced net revenues for fiscal year 2012 of $60,943,000, an increase of $8,245,000, or 15.6%, compared with sales of $52,698,000 for fiscal year 2011. The increase in sales was primarily due to the Company's continued direct response advertising campaign to acquire new customers and its emphasis on customer service to maximize the reorder rates for its recurring customer base. Liberator's direct response advertising expenditure for fiscal year 2012 was $13,113,000, compared to $15,245,000 for fiscal year 2011. For the fourth quarter of fiscal 2012, the Company reported net revenues of $16,516,000, representing a 10.4% increase over third quarter 2012 net revenues of $14,961,000.

Net income for fiscal year 2012 increased by $2,242,000, or 866%, to $2,501,000, compared with fiscal year 2011 net income of $259,000. Net income for fiscal year 2011 included a $902,000 non-cash expense for the change in fair value of an embedded derivative, which was eliminated upon conversion of a convertible note during the first quarter of fiscal year 2011. The balance of the increase in net income was driven by increased sales volumes and improved operating margins during fiscal year 2012.

Financial Condition

The Company had cash of $3,326,000 at September 30, 2012, compared with $3,016,000 at September 30, 2011, an increase of $310,000. This increase in cash during fiscal year 2012 was primarily due to $1,000,000 of borrowings from its credit line facility, partially offset by $546,000 in net cash used in operating activities and $151,000 for purchases of property and equipment.

Cash used in operating activities in fiscal 2012 was $546,000, which represents an improvement of $3,947,000 compared with cash used in operating activities of $4,493,000 during fiscal year 2011. The improvement in operating cash flows during fiscal year 2012 was primarily driven by additional net income of $2,242,000, a reduction in direct response advertising spend of $2,132,000, partially offset by a decrease in changes in operating assets and liabilities of $449,000.

Mark Libratore, President and Chief Executive Officer, stated: "We are very proud of our financial performance during fiscal year 2012. We increased our sales by 15% over last year, reduced our customer acquisition costs, increased our operating margins, and improved our operating cash flows for 2012. We will continue to invest in new technology and implement process improvements during fiscal year 2013 that we believe will improve overall productivity and contribute to increased profitability, while providing excellent service to our growing customer base.

We expect to manage the levels of our direct response advertising spend to maximize profitability and cash flows for fiscal year 2013, which may result in slower top-line sales growth. Based on our financial results from fiscal year 2012, we expect to continue to improve operating margins and cash flows for fiscal year 2013."

Stay up-to-date with current events by visiting Liberator Medical's website at www.liberatormedical.com or by joining the Company's E-Mail Alert List. Join by clicking the following link www.LBMH-IR.com.

About Liberator Medical Holdings, Inc.

Liberator Medical Holdings, Inc.'s subsidiary, Liberator Medical Supply, Inc., established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible seniors. Accredited by The Joint Commission, its unique combination of marketing, industry expertise and customer service has demonstrated success over a broad spectrum of chronic conditions. Liberator is recognized for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance. Liberator's revenue primarily comes from supplying products to meet the rapidly growing requirements of general medical supplies, personal mobility aids, diabetes, urological, ostomy and mastectomy patients. Liberator communicates with patients and their doctors on a regular basis regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.

 

                                                                            
                                                                            
             Liberator Medical Holdings, Inc. and Subsidiaries              
                        Consolidated Balance Sheets                         
                     As of September 30, 2012 and 2011                      
              (In thousands, except dollar per share amounts)               
                                                                            
                                                        2012        2011    
                                                     ----------  ---------- 
                                                                            
                       Assets                                               
Current Assets:                                                             
  Cash                                               $    3,326  $    3,016 
  Accounts receivable, net of allowances of $5,044                          
   and $4,177, respectively                              10,365       7,860 
  Inventory, net of allowance for obsolete inventory                        
   of $310 and $144, respectively                         2,627       3,009 
  Deferred taxes, current portion                         2,254       1,877 
   Prepaid and other current assets                         287         333 
                                                     ----------  ---------- 
    Total Current Assets                                 18,859      16,095 
Property and equipment, net of accumulated                                  
 depreciation of $2,888 and $2,186, respectively          1,250       1,626 
Deferred advertising                                     22,426      17,191 
Intangible assets, net of accumulated amortization                          
 of $91 and $25, respectively                               239         305 
Other assets                                                 88         163 
                                                     ----------  ---------- 
                                                                            
Total Assets                                         $   42,862  $   35,380 
                                                     ==========  ========== 
                                                                            
        Liabilities and Stockholders' Equity                                
Current Liabilities:                                                        
  Accounts payable                                   $    6,537  $    5,008 
  Accrued liabilities                                     1,221       1,119 
  Other current liabilities                                  92         103 
                                                     ----------  ---------- 
    Total Current Liabilities                             7,850       6,230 
Deferred tax liability                                    5,421       3,347 
Credit line facility                                      2,500       1,500 
Other long-term liabilities                                 132          48 
                                                     ----------  ---------- 
Total Liabilities                                        15,903      11,125 
                                                     ----------  ---------- 
                                                                            
Commitments and contingencies (see Note 13)                                 
                                                                            
Stockholders' Equity:                                                       
Common stock, $.001 par value, 200,000 shares                               
 authorized, 48,232 and 48,135 shares issued,                               
 respectively; 48,143 and 48,046 shares outstanding                         
 at September 30, 2012 and 2011, respectively                48          48 
Additional paid-in capital                               34,707      34,504 
Accumulated deficit                                      (7,746)    (10,247)
Treasury stock, at cost; 89 shares at September 30,                         
 2012 and 2011, respectively                                (50)        (50)
                                                     ----------  ---------- 
                                                                            
Total Stockholders' Equity                               26,959      24,255 
                                                     ----------  ---------- 
                                                                            
Total Liabilities and Stockholders' Equity           $   42,862  $   35,380 
                                                     ==========  ========== 
                                                                            

See accompanying notes to consolidated financial statements

  

                                                                            
             Liberator Medical Holdings, Inc. and Subsidiaries              
                   Consolidated Statements of Operations                    
           For the fiscal years ended September 30, 2012 and 2011           
              (In thousands, except dollar per share amounts)               
                                                                            
                                                        2012        2011    
                                                     ----------  ---------- 
                                                                            
Net Sales                                            $   60,943  $   52,698 
                                                                            
Cost of Sales                                            23,924      20,601 
                                                                            
                                                     ----------  ---------- 
Gross Profit                                             37,019      32,097 
                                                     ----------  ---------- 
                                                                            
Operating Expenses:                                                         
  Payroll, taxes and benefits                            14,136      12,174 
  Advertising                                             8,099       8,206 
  Bad debts                                               4,664       3,746 
  Depreciation and amortization                             794         730 
  General and administrative                              5,019       4,644 
                                                     ----------  ---------- 
    Total Operating Expenses                             32,712      29,500 
                                                     ----------  ---------- 
                                                                            
Income from Operations                                    4,307       2,597 
                                                     ----------  ---------- 
                                                                            
                                                                            
Other Income (Expense)                                                      
  Gain on sale of assets                                      -           2 
  Interest expense                                          (75)        (42)
  Interest income                                             -           5 
  Change in fair value of derivative liabilities              -        (902)
                                                     ----------  ---------- 
    Total Other Income (Expense)                            (75)       (937)
                                                     ----------  ---------- 
                                                                            
                                                                            
Income before Income Taxes                                4,232       1,660 
                                                                            
Provision for Income Taxes                                1,731       1,401 
                                                     ----------  ---------- 
                                                                            
Net Income                                           $    2,501  $      259 
                                                     ==========  ========== 
                                                                            
                                                                            
Basic earnings per share:                                                   
Weighted average shares outstanding                      48,097      47,869 
Earnings per share                                   $     0.05  $     0.01 
                                                                            
Diluted earnings per share:                                                 
Weighted average shares outstanding                      52,266      53,613 
Earnings per share                                   $     0.05  $     0.00 

See accompanying notes to consolidated financial statements

 

             Liberator Medical Holdings, Inc. and Subsidiaries              
                   Consolidated Statements of Cash Flows                    
           For the fiscal years ended September 30, 2012 and 2011           
                               (In thousands)                               
                                                        2012        2011    
                                                     ----------  ---------- 
                                                                            
Cash flow from operating activities:                                        
  Net income                                         $    2,501  $      259 
                                                                            
  Adjustments to reconcile net income to net cash                           
   used in operating activities:                                            
    Depreciation and amortization                         8,672       8,790 
    Equity based compensation                               122         385 
    Provision for doubtful accounts and contractual                         
     adjustments                                          4,787       3,950 
    Non-cash interest related to convertible notes                          
     payable                                                  -          21 
    Change in fair value of derivative liabilities            -         902 
    Deferred income taxes                                 1,697       1,340 
    Reserve for inventory obsolescence                      166          35 
    Gain on disposal of assets                                -          (2)
  Changes in operating assets and liabilities:                              
    Accounts receivable                                  (7,293)     (5,065)
    Deferred advertising                                (13,113)    (15,245)
    Inventory                                               216      (1,025)
    Other assets                                            143          49 
    Accounts payable                                      1,529       1,182 
    Accrued expenses                                        116          13 
    Other liabilities                                       (89)        (83)
                                                     ----------  ---------- 
Net Cash Flows Used in Operating Activities                (546)     (4,494)
                                                     ----------  ---------- 
                                                                            
Cash flows from investing activities                                        
  Purchase of property and equipment and other             (151)       (369)
  Acquisition of SGV Medical Supplies (see Note 10)           -        (466)
  Proceeds from the sale of assets                            -           3 
                                                     ----------  ---------- 
Net Cash Flows Used in Investing Activities                (151)       (832)
                                                     ----------  ---------- 
                                                                            
Cash flows from financing activities                                        
  Proceeds from credit line facility                      1,000       1,500 
  Costs associated with credit line facility                (21)        (51)
  Proceeds from employee stock purchase plan                 67          86 
  Payments of debt and capital lease obligations            (39)       (621)
                                                     ----------  ---------- 
                                                                            
Net Cash Flows Provided by Financing Activities           1,007         914 
                                                     ----------  ---------- 
                                                                            
Net increase (decrease) in cash                             310      (4,412)
                                                                            
Cash at beginning of period                               3,016       7,428 
                                                     ----------  ---------- 
Cash at end of period                                $    3,326  $    3,016 
                                                     ==========  ========== 
                                                                            
Supplemental disclosure of cash flow information:                           
Cash paid for interest                               $       73  $       56 
Cash refunded for income taxes                                -          (8)
                                                                            
Supplemental schedule of non-cash investing and                             
 financing activities:                                                      
Capital expenditures funded by capital lease                                
 borrowings                                                 202           - 
Common stock issued for conversion of debt                    -       5,100 

See accompanying notes to consolidated financial statements

Safe Harbor Statement

In this press release and in related comments by our management, our use of the words "expect," "anticipate," "possible," "potential," "target," "believe," "commit," "intend," "continue," "may," "would," "could," "should," "project," "projected," "positioned" or similar expressions is intended to identify forward-looking statements that represent our current judgment about possible future events. We believe these judgments are reasonable, but these statements are not guarantees of any events or financial results, and our actual results may differ materially due to a variety of important factors. Such risks and uncertainties may include, but are not limited to, regulatory limitations on the medical industry in general, working capital constraints, fluctuations in customer demand and commitments, fluctuation in quarterly results, introduction of new services and products, commercial acceptance and viability of new services and products, pricing and competition, reliance upon subcontractors and vendors, the timing of new technology and product introductions, and the risk of early obsolescence of our products. Liberator's most recent annual report on Form 10-K and quarterly reports on Form 10-Q provide information about these and other factors, which we may revise or supplement in future reports filed with the Securities and Exchange Commission.

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

@ThingsExpo Stories
Multiple data types are pouring into IoT deployments. Data is coming in small packages as well as enormous files and data streams of many sizes. Widespread use of mobile devices adds to the total. In this power panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists looked at the tools and environments that are being put to use in IoT deployments, as well as the team skills a modern enterprise IT shop needs to keep things running, get a handle on all this data, and deliver...
In his session at @ThingsExpo, Eric Lachapelle, CEO of the Professional Evaluation and Certification Board (PECB), provided an overview of various initiatives to certify the security of connected devices and future trends in ensuring public trust of IoT. Eric Lachapelle is the Chief Executive Officer of the Professional Evaluation and Certification Board (PECB), an international certification body. His role is to help companies and individuals to achieve professional, accredited and worldwide re...
The current age of digital transformation means that IT organizations must adapt their toolset to cover all digital experiences, beyond just the end users’. Today’s businesses can no longer focus solely on the digital interactions they manage with employees or customers; they must now contend with non-traditional factors. Whether it's the power of brand to make or break a company, the need to monitor across all locations 24/7, or the ability to proactively resolve issues, companies must adapt to...
IoT solutions exploit operational data generated by Internet-connected smart “things” for the purpose of gaining operational insight and producing “better outcomes” (for example, create new business models, eliminate unscheduled maintenance, etc.). The explosive proliferation of IoT solutions will result in an exponential growth in the volume of IoT data, precipitating significant Information Governance issues: who owns the IoT data, what are the rights/duties of IoT solutions adopters towards t...
With the introduction of IoT and Smart Living in every aspect of our lives, one question has become relevant: What are the security implications? To answer this, first we have to look and explore the security models of the technologies that IoT is founded upon. In his session at @ThingsExpo, Nevi Kaja, a Research Engineer at Ford Motor Company, discussed some of the security challenges of the IoT infrastructure and related how these aspects impact Smart Living. The material was delivered interac...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend 21st Cloud Expo October 31 - November 2, 2017, at the Santa Clara Convention Center, CA, and June 12-14, 2018, at the Javits Center in New York City, NY, and learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
No hype cycles or predictions of zillions of things here. IoT is big. You get it. You know your business and have great ideas for a business transformation strategy. What comes next? Time to make it happen. In his session at @ThingsExpo, Jay Mason, Associate Partner at M&S Consulting, presented a step-by-step plan to develop your technology implementation strategy. He discussed the evaluation of communication standards and IoT messaging protocols, data analytics considerations, edge-to-cloud tec...
New competitors, disruptive technologies, and growing expectations are pushing every business to both adopt and deliver new digital services. This ‘Digital Transformation’ demands rapid delivery and continuous iteration of new competitive services via multiple channels, which in turn demands new service delivery techniques – including DevOps. In this power panel at @DevOpsSummit 20th Cloud Expo, moderated by DevOps Conference Co-Chair Andi Mann, panelists examined how DevOps helps to meet the de...
When growing capacity and power in the data center, the architectural trade-offs between server scale-up vs. scale-out continue to be debated. Both approaches are valid: scale-out adds multiple, smaller servers running in a distributed computing model, while scale-up adds fewer, more powerful servers that are capable of running larger workloads. It’s worth noting that there are additional, unique advantages that scale-up architectures offer. One big advantage is large memory and compute capacity...
The Internet giants are fully embracing AI. All the services they offer to their customers are aimed at drawing a map of the world with the data they get. The AIs from these companies are used to build disruptive approaches that cannot be used by established enterprises, which are threatened by these disruptions. However, most leaders underestimate the effect this will have on their businesses. In his session at 21st Cloud Expo, Rene Buest, Director Market Research & Technology Evangelism at Ara...
"When we talk about cloud without compromise what we're talking about is that when people think about 'I need the flexibility of the cloud' - it's the ability to create applications and run them in a cloud environment that's far more flexible,” explained Matthew Finnie, CTO of Interoute, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
Artificial intelligence, machine learning, neural networks. We’re in the midst of a wave of excitement around AI such as hasn’t been seen for a few decades. But those previous periods of inflated expectations led to troughs of disappointment. Will this time be different? Most likely. Applications of AI such as predictive analytics are already decreasing costs and improving reliability of industrial machinery. Furthermore, the funding and research going into AI now comes from a wide range of com...
Internet of @ThingsExpo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devic...
SYS-CON Events announced today that MobiDev, a client-oriented software development company, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. MobiDev is a software company that develops and delivers turn-key mobile apps, websites, web services, and complex software systems for startups and enterprises. Since 2009 it has grown from a small group of passionate engineers and business...
SYS-CON Events announced today that GrapeUp, the leading provider of rapid product development at the speed of business, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Grape Up is a software company, specialized in cloud native application development and professional services related to Cloud Foundry PaaS. With five expert teams that operate in various sectors of the market acr...
SYS-CON Events announced today that Ayehu will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on October 31 - November 2, 2017 at the Santa Clara Convention Center in Santa Clara California. Ayehu provides IT Process Automation & Orchestration solutions for IT and Security professionals to identify and resolve critical incidents and enable rapid containment, eradication, and recovery from cyber security breaches. Ayehu provides customers greater control over IT infras...
In this presentation, Striim CTO and founder Steve Wilkes will discuss practical strategies for counteracting fraud and cyberattacks by leveraging real-time streaming analytics. In his session at @ThingsExpo, Steve Wilkes, Founder and Chief Technology Officer at Striim, will provide a detailed look into leveraging streaming data management to correlate events in real time, and identify potential breaches across IoT and non-IoT systems throughout the enterprise. Strategies for processing massive ...
SYS-CON Events announced today that Cloud Academy named "Bronze Sponsor" of 21st International Cloud Expo which will take place October 31 - November 2, 2017 at the Santa Clara Convention Center in Santa Clara, CA. Cloud Academy is the industry’s most innovative, vendor-neutral cloud technology training platform. Cloud Academy provides continuous learning solutions for individuals and enterprise teams for Amazon Web Services, Microsoft Azure, Google Cloud Platform, and the most popular cloud com...
In his session at Cloud Expo, Alan Winters, an entertainment executive/TV producer turned serial entrepreneur, presented a success story of an entrepreneur who has both suffered through and benefited from offshore development across multiple businesses: The smart choice, or how to select the right offshore development partner Warning signs, or how to minimize chances of making the wrong choice Collaboration, or how to establish the most effective work processes Budget control, or how to ma...
SYS-CON Events announced today that Enzu will exhibit at SYS-CON's 21st Int\ernational Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Enzu’s mission is to be the leading provider of enterprise cloud solutions worldwide. Enzu enables online businesses to use its IT infrastructure to their competitive advantage. By offering a suite of proven hosting and management services, Enzu wants companies to focus on the core of their ...